Halozyme
HALO
386 hedge funds and large institutions have $4.77B invested in Halozyme in 2023 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 139 increasing their positions, 153 reducing their positions, and 80 closing their positions.
397% more call options, than puts
Call options by funds: $20.7M | Put options by funds: $4.17M
9% less repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 153
3.38% less ownership
Funds ownership: 95.58% → 92.2% (-3.4%)
9% less funds holding
Funds holding: 423 → 386 (-37)
34% less capital invested
Capital invested by funds: $7.26B → $4.77B (-$2.5B)
36% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 80
78% less funds holding in top 10
Funds holding in top 10: 18 → 4 (-14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$54.3M |
| 2 |
Millennium Management
New York
|
+$45.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$41.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$27.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$211M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$118M |
| 3 |
TCM
Tran Capital Management
San Rafael,
California
|
-$61.7M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$55.1M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$39.5M |
HALO Hedge Fund Activity: Q1 2023 in Review
386 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2023, worth a combined $4.77B — down 34% from $7.26B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of HALO and 51 opened new positions — a net loss of 29 holders — while 153 trimmed existing stakes and 139 added.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $54.3M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $211M sold.
- 386 institutional investors held Halozyme (HALO) as of Q1 2023, down from 423 in Q4 2022.
- Funds reported $4.77B of Halozyme stock for Q1 2023, down 34% quarter-over-quarter.
- 51 funds opened new Halozyme positions in Q1 2023 and 80 closed out, a net change of -29 holders.
- The largest Halozyme buyer in Q1 2023 was ArrowMark Colorado Holdings, an estimated $54.3M added.
- The largest Halozyme seller in Q1 2023 was William Blair Investment Management, an estimated $211M sold.
Based on aggregated 13F filings for Q1 2023.